Literature DB >> 18999217

Survival prediction models for estimating the benefit of post-operative radiation therapy for gallbladder cancer and lung cancer.

Jayashree Kalpathy-Cramer1, William Hersh, Jong Song Kim, Charles R Thomas, Samuel J Wang.   

Abstract

The role of post-operative radiotherapy (PORT) is still controversial for some cancer sites. In the absence of large randomized controlled trials, survival prediction models can help estimate the predicted benefit of PORT for specific settings. The purpose of this study was to compare the performance of two types of prediction models for estimating the benefit of PORT for 2 cancer sites. Using data from the Surveillance, Epidemiology, and End Results database, we constructed prediction models for gallbladder (GB) cancer and non-small cell lung cancer (NSMLC), using Cox proportional hazards and Random Survival Forests. We compared validation measures for discrimination and found that both the CPH and RSF models had comparable C-indices. For GB cancer, PORT was associated with improved survival for node positive patients, and for NSCLC, PORT was associated with a survival benefit for patients with N2 disease.

Entities:  

Mesh:

Year:  2008        PMID: 18999217      PMCID: PMC2656000     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  5 in total

1.  Survival ensembles.

Authors:  Torsten Hothorn; Peter Bühlmann; Sandrine Dudoit; Annette Molinaro; Mark J van der Laan
Journal:  Biostatistics       Date:  2005-12-12       Impact factor: 5.899

2.  Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience.

Authors:  Brian G Czito; Herbert I Hurwitz; Robert W Clough; Douglas S Tyler; Michael A Morse; Bryan M Clary; Theodore N Pappas; Nishan H Fernando; Christopher G Willett
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-15       Impact factor: 7.038

3.  Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database.

Authors:  Brian E Lally; Daniel Zelterman; Joseph M Colasanto; Bruce G Haffty; Frank C Detterbeck; Lynn D Wilson
Journal:  J Clin Oncol       Date:  2006-06-12       Impact factor: 44.544

4.  Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer.

Authors:  Samuel J Wang; C David Fuller; Jong-Sung Kim; Dean F Sittig; Charles R Thomas; Peter M Ravdin
Journal:  J Clin Oncol       Date:  2008-03-31       Impact factor: 44.544

5.  The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease. Medical Research Council Lung Cancer Working Party.

Authors:  R J Stephens; D J Girling; N M Bleehen; K Moghissi; H M Yosef; D Machin
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

  5 in total
  1 in total

1.  Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.

Authors:  Samuel J Wang; Andrew Lemieux; Jayashree Kalpathy-Cramer; Celine B Ord; Gary V Walker; C David Fuller; Jong-Sung Kim; Charles R Thomas
Journal:  J Clin Oncol       Date:  2011-11-07       Impact factor: 44.544

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.